217 related articles for article (PubMed ID: 10699184)
1. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.
Groenen PJ; Wansink DG; Coerwinkel M; van den Broek W; Jansen G; Wieringa B
Hum Mol Genet; 2000 Mar; 9(4):605-16. PubMed ID: 10699184
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
3. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.
Amack JD; Paguio AP; Mahadevan MS
Hum Mol Genet; 1999 Oct; 8(11):1975-84. PubMed ID: 10484765
[TBL] [Abstract][Full Text] [Related]
4. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
Tiscornia G; Mahadevan MS
Mol Cell; 2000 Jun; 5(6):959-67. PubMed ID: 10911990
[TBL] [Abstract][Full Text] [Related]
6. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization.
Wansink DG; van Herpen RE; Coerwinkel-Driessen MM; Groenen PJ; Hemmings BA; Wieringa B
Mol Cell Biol; 2003 Aug; 23(16):5489-501. PubMed ID: 12897125
[TBL] [Abstract][Full Text] [Related]
8. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
[TBL] [Abstract][Full Text] [Related]
9. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK).
Forner F; Furlan S; Salvatori S
Biochim Biophys Acta; 2010 Jun; 1804(6):1334-41. PubMed ID: 20188867
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy protein kinase (DMPK) gene expression in lymphocytes of patients with myotonic dystrophy.
Depardon F; Cisneros B; Alonso-Vilatela E; Montañez C
Arch Med Res; 2001; 32(2):123-8. PubMed ID: 11343809
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
[TBL] [Abstract][Full Text] [Related]
13. Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibers.
Eriksson M; Hedberg B; Carey N; Ansved T
Biochem Biophys Res Commun; 2001 Sep; 286(5):1177-82. PubMed ID: 11527424
[TBL] [Abstract][Full Text] [Related]
14. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice.
Guiraud-Dogan C; Huguet A; Gomes-Pereira M; Brisson E; Bassez G; Junien C; Gourdon G
Biochim Biophys Acta; 2007 Dec; 1772(11-12):1183-91. PubMed ID: 17950578
[TBL] [Abstract][Full Text] [Related]
15. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.
Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH
Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart.
Lam LT; Pham YC; Nguyen TM; Morris GE
Hum Mol Genet; 2000 Sep; 9(14):2167-73. PubMed ID: 10958655
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.
Winchester CL; Ferrier RK; Sermoni A; Clark BJ; Johnson KJ
Hum Mol Genet; 1999 Mar; 8(3):481-92. PubMed ID: 9949207
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy and myotonic dystrophy protein kinase.
Ueda H; Ohno S; Kobayashi T
Prog Histochem Cytochem; 2000; 35(3):187-251. PubMed ID: 11064921
[TBL] [Abstract][Full Text] [Related]
20. AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.
Stepniak-Konieczna E; Konieczny P; Cywoniuk P; Dluzewska J; Sobczak K
Nucleic Acids Res; 2020 Mar; 48(5):2531-2543. PubMed ID: 31965181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
